Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
NCT03119584Phase 4Active, not recruiting
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Sep 2015
- Primary completion
- Oct 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of linaclotide in chronic constipation (2 arms), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Improvement in frequency of bowel movements at 10 weeks. Started Sep 2015; status: active, not recruiting.
02
Drugs
linaclotide
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT03119584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03119584.